MeSH term
Frequency | Condition_Probility | Age Distribution | 2 | 0.0 |
Aged | 10 | 0.0 |
Alleles | 16 | 0.0 |
Carrier Proteins/*genetics | 29 | 2.0 |
Cohort Studies | 6 | 0.0 |
Fatty Acids/*metabolism | 3 | 3.0 |
Female | 28 | 0.0 |
Humans | 50 | 0.0 |
Lipids/blood | 4 | 0.0 |
Lipoproteins/*blood | 4 | 0.0 |
Male | 30 | 0.0 |
Middle Aged | 22 | 0.0 |
*Neoplasm Proteins | 34 | 4.0 |
*Polymorphism, Genetic | 15 | 0.0 |
Prospective Studies | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Risk Factors | 6 | 0.0 |
Sex Distribution | 2 | 0.0 |
*Tumor Suppressor Proteins | 37 | 2.0 |
*Variation (Genetics) | 5 | 0.0 |
Adult | 16 | 0.0 |
Heterozygote | 6 | 0.0 |
Insulin/blood | 4 | 0.0 |
Obesity/blood/*genetics | 3 | 23.0 |
Triglycerides/*blood | 2 | 0.0 |
Amino Acid Substitution/genetics | 2 | 0.0 |
Blood Pressure | 2 | 0.0 |
Body Mass Index | 10 | 0.0 |
Gene Frequency | 11 | 0.0 |
Genotype | 16 | 0.0 |
Insulin Resistance/*genetics | 11 | 13.0 |
Receptors, Adrenergic, beta-3/*genetics | 2 | 10.0 |
Alanine/genetics | 6 | 5.0 |
Codon | 4 | 0.0 |
Threonine/genetics | 6 | 8.0 |
Body Composition/physiology | 2 | 3.0 |
Estrogen Replacement Therapy | 2 | 4.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
Glucose Tolerance Test | 6 | 1.0 |
Postmenopause | 2 | 1.0 |
Carrier Proteins/*genetics/metabolism | 3 | 1.0 |
Homozygote | 5 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Apolipoproteins/*genetics | 2 | 2.0 |
Arteriosclerosis/etiology/*genetics | 2 | 50.0 |
Diet | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Lipids/*blood | 5 | 0.0 |
*Alanine | 2 | 11.0 |
Apolipoproteins E/genetics | 2 | 0.0 |
Blood Glucose/metabolism | 4 | 0.0 |
Cholesterol/blood | 7 | 0.0 |
DNA/blood | 2 | 1.0 |
Fatty Acids/metabolism | 5 | 4.0 |
Triglycerides/blood | 4 | 0.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
Cross-Sectional Studies | 3 | 0.0 |
Phenotype | 5 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
European Continental Ancestry Group/*genetics | 2 | 0.0 |
*Genetic Predisposition to Disease | 4 | 0.0 |
Animals | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
*Diet | 2 | 0.0 |
Dietary Fats/*pharmacology | 2 | 3.0 |
Intestines/*metabolism | 4 | 5.0 |
Comparative Study | 9 | 0.0 |
Diabetes Mellitus, Type 2/genetics | 2 | 4.0 |
Myelin P2 Protein/*genetics | 12 | 70.0 |
Variation (Genetics) | 6 | 0.0 |
Apolipoproteins C/*genetics | 3 | 3.0 |
Apolipoproteins E/*genetics | 2 | 0.0 |
Chromosomes, Human, Pair 11 | 2 | 0.0 |
Genetic Markers | 5 | 0.0 |
Polymorphism, Genetic | 8 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Genetic Screening | 2 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Diabetes Mellitus, Type 2/*genetics | 5 | 3.0 |
Obesity/*genetics | 3 | 2.0 |
Phosphoproteins/*genetics | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Glucose Intolerance/genetics | 2 | 33.0 |
Japan | 4 | 0.0 |
Reference Values | 2 | 0.0 |
*Codon | 2 | 4.0 |
Cross-Over Studies | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Aryldialkylphosphatase | 2 | 1.0 |
Carrier Proteins/genetics | 3 | 0.0 |
Disease Susceptibility | 2 | 0.0 |
Indians, North American/*genetics | 5 | 5.0 |
Finland | 4 | 1.0 |
Insulin Resistance/genetics | 3 | 7.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Family | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
*Chromosomes, Human, Pair 4 | 4 | 1.0 |
Lod Score | 2 | 0.0 |
Arizona | 2 | 6.0 |
Glucose Clamp Technique | 2 | 1.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
Lipoproteins, LDL Cholesterol/blood | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
*Dietary Fats | 2 | 9.0 |
Diabetes Mellitus, Type 2/*genetics/physiopathology | 2 | 20.0 |